On March 17, 2026, the Hong Kong Biotechnology Organization (HKBIO) in partnership with the Netherlands Consulate General in Hong Kong and Macau successfully concluded a high-level closed-door biotech exchange. This event brought together representatives from the Dutch Ministry of Economic Affairs, Ministry of Health, Welfare and Sport, Netherlands Foreign Investment Agency, and other government bodies, alongside leading industry parks such as Pivot Park, top research institutions including Radboud University Medical Center, University of Groningen, and TNO, as well as innovative biotech companies like Constellate Proteomics, and AVIGI Therapeutics. Over 50 members of Hong Kong’s biotech community participated, united by a shared goal: to foster innovation, deepen industry collaboration, and unlock new business opportunities.
